Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ePoster Display

921P - Assessment of health-related quality of life in head and neck cancer patients treated with chemoradiation

Date

16 Sep 2021

Session

ePoster Display

Topics

Survivorship;  Supportive and Palliative Care

Tumour Site

Head and Neck Cancers

Presenters

VINAYAKUMAR MUTTAGI

Citation

Annals of Oncology (2021) 32 (suppl_5): S786-S817. 10.1016/annonc/annonc704

Authors

V. MUTTAGI1, P. Ahlawat2, M. Gairola3, S. Tandon2, S. Purohit3, K. Dobriyal3, P. Umesh3, J. Mukhee2

Author affiliations

  • 1 Near By Sarvagna Circle, Shiralkoppa Road, Haveri, Karnataka - 581111, HCG Bangalore Institute of Oncology Speciality Centre, 560027 - Bangalore/IN
  • 2 New Delhi, India, Rajiv Gandhi Cancer Institute & Research Centre, 110085 - Delhi/IN
  • 3 Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, 110085 - New Delhi/IN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 921P

Background

Head and neck cancer (HNC) patients face poor health-related quality of life (HRQoL) issues. HRQOL is a self-reported, subjective, multidimensional phenomenon that changes over time. Hence, HRQoL apart from other outcomes such as disease free survival and overall survival has been increasingly being considered an important outcome of future studies. This study aimed to understand the progression of QoL from diagnosis, through treatment and at 3 months after treatment, and to determine main determinants of QOL in locally advanced HNC undergoing radical chemoradiation (CRT).

Methods

It was a prospective study in which 100 consecutive HNC patients undergoing CRT filled Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N)-V4 questionnaire at pretreatment stage, weekly during CRT and at 3 months after completion of CRT. Data was statistically tested through multivariate analysis of variance and regression modeling to identify the potentially associated factors.

Results

Chemoradiation elicited statistically significant worsening of physical well-being, social well-being, emotional well-being, functional well-being, FACT –G, and FACT- H&N score over time (from pretreatment to end of each successive week, and at 3 months post CRT). Tumor stage and tumor site had the strongest negative impact on patients HRQoL.

Conclusions

HRQoL is a self-reported, subjective, multidimensional phenomenon that changes over time. Regular use of HRQoL questioner can be incorporated in daily clinical practice for head and neck cancer treatment. This will encourage us for holistic care of cancer patients.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.